BIO
BIO-RAD LABORATORIES, INC.Company Information
- Company Name
- BIO-RAD LABORATORIES, INC.
- CIK
- CIK0000012208
- Category
- Large accelerated filer
- Ticker: Exchange
- BIO: NYSE, BIO-B: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3826
- SIC Description
- Laboratory Analytical Instruments
- Ticker
- BIO
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-05-11
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 1,249.87
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 18,812,423
- Shares outstanding
- 26,746,000
- Ownership
- 70.34%
Earnings Market Reaction
- Filing date
- 2026-08-04
- Price on filing date
- —
- 1-month reaction
- 16.47%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Treasury Stock Common | 0 | 3 | - | 1,003 | -133 | -867 | - | -54 | -94 | -630 | - | 22 | ||||||
| Cash And Cash Equivalents At Carrying Value | 517 | 507 | 530 | 396 | 369 | 521 | 488 | 410 | 407 | 433 | 404 | 458 | ||||||
| Short Term Investments | 1,102 | 1,058 | 1,011 | 1,023 | 1,005 | 1,139 | 1,176 | 1,212 | 1,209 | 1,212 | 1,203 | 1,301 | ||||||
| Accounts Receivable Net Current | 442 | 426 | 461 | 465 | 470 | 425 | 453 | 462 | 446 | 445 | 489 | 457 | ||||||
| Restricted Investments Current | - | - | - | - | - | - | 0 | 6 | 6 | 6 | 6 | 6 | ||||||
| Inventory Net | 781 | 771 | 741 | 783 | 799 | 790 | 760 | 804 | 804 | 783 | 781 | 776 | ||||||
| Prepaid Expense Current | 148 | 150 | 137 | 152 | 150 | 125 | 123 | 133 | 153 | 143 | 140 | 124 | ||||||
| Other Assets Current | 32 | 31 | 28 | 24 | 19 | 36 | 31 | 28 | 32 | 39 | 26 | 25 | ||||||
| Assets Current | 3,021 | 2,942 | 2,906 | 2,842 | 2,811 | 3,037 | 3,030 | 3,056 | 3,056 | 3,061 | 3,048 | 3,147 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization | - | - | - | - | - | - | - | - | - | - | - | 1,539 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization | - | - | - | - | - | - | - | - | - | - | - | 1,027 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 518 | 528 | 540 | 540 | 550 | 529 | 528 | 545 | 534 | 522 | 529 | 511 | ||||||
| Operating Lease Right Of Use Asset | 154 | 162 | 170 | 180 | 190 | 153 | 161 | 174 | 181 | 189 | 195 | 200 | ||||||
| Goodwill | 574 | 577 | 580 | 579 | 582 | 415 | 411 | 415 | 412 | 413 | 414 | 407 | ||||||
| Intangible Assets Net Excluding Goodwill | 160 | 167 | 174 | 388 | 397 | 296 | 294 | 307 | 307 | 314 | 321 | 314 | ||||||
| Long Term Investments | 5,724 | 5,312 | 6,104 | 5,058 | 5,577 | 4,994 | 4,839 | 6,003 | 5,100 | 8,018 | 7,698 | 7,218 | ||||||
| Other Assets Noncurrent | - | - | 103 | - | - | - | 102 | - | - | - | 95 | - | ||||||
| Other Assets | 102 | 103 | - | 109 | 108 | 104 | - | 104 | 98 | 93 | - | 98 | ||||||
| Assets | 10,252 | 9,790 | 10,577 | 9,696 | 10,214 | 9,527 | 9,364 | 10,603 | 9,688 | 12,610 | 12,299 | 11,896 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 144 | 133 | 129 | 129 | 139 | 138 | 122 | 122 | 127 | 103 | 145 | 112 | ||||||
| Employee Related Liabilities Current | 151 | 148 | 172 | 183 | 158 | 157 | 124 | 146 | 132 | 146 | 140 | 155 | ||||||
| Notes And Loans Payable Current | 401 | 401 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | ||||||
| Accrued Income Taxes Current | - | - | 37 | - | - | - | 31 | - | - | - | 36 | - | ||||||
| Taxes Payable Current | 74 | 45 | - | 45 | 36 | 37 | - | 44 | 36 | 34 | - | 104 | ||||||
| Operating Lease Liability Current | 34 | 36 | 36 | 37 | 39 | 41 | 42 | 43 | 42 | 40 | 40 | 39 | ||||||
| Other Liabilities Current | 159 | 154 | 142 | 128 | 175 | 132 | 147 | 142 | 150 | 142 | 162 | 148 | ||||||
| Liabilities Current | 961 | 917 | 517 | 522 | 549 | 507 | 468 | 498 | 487 | 466 | 523 | 558 | ||||||
| Long Term Debt Noncurrent | 803 | 803 | 1,202 | 1,201 | 1,201 | 1,201 | 1,200 | 1,200 | 1,200 | 1,199 | 1,199 | 1,199 | ||||||
| Deferred Income Tax Liabilities Net | 982 | 882 | 1,059 | 873 | 961 | 841 | 818 | 1,076 | 878 | 1,541 | 1,476 | 1,370 | ||||||
| Operating Lease Liability Noncurrent | 133 | 139 | 146 | 156 | 165 | 126 | 131 | 144 | 151 | 160 | 166 | 167 | ||||||
| Other Liabilities Noncurrent | 199 | 198 | 199 | 208 | 210 | 173 | 177 | 198 | 194 | 192 | 195 | 186 | ||||||
| Liabilities | 3,078 | 2,939 | 3,123 | 2,960 | 3,085 | 2,848 | 2,795 | 3,116 | 2,910 | 3,559 | 3,558 | 3,480 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Additional Paid In Capital | 503 | 491 | 476 | 462 | 485 | 476 | 463 | 448 | 475 | 463 | 449 | 439 | ||||||
| Treasury Stock Value | - | - | -1,010 | - | - | - | -772 | - | - | - | -633 | - | ||||||
| Retained Earnings Accumulated Deficit | 8,021 | 7,649 | 8,176 | 7,456 | 7,798 | 7,480 | 7,416 | 8,132 | 7,479 | 9,645 | 9,261 | 8,911 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -271 | -235 | -189 | -167 | -154 | -410 | -538 | -315 | -451 | -426 | -336 | -498 | ||||||
| Stockholders Equity | 7,174 | 6,851 | 7,454 | 6,737 | 7,129 | 6,679 | 6,569 | 7,488 | 6,779 | 9,051 | 8,741 | 8,416 | ||||||
| Liabilities And Stockholders Equity | 10,252 | 9,790 | 10,577 | 9,696 | 10,214 | 9,527 | 9,364 | 10,603 | 9,688 | 12,610 | 12,299 | 11,896 | ||||||
| Common Stock | - | - | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Common Class A | - | - | 22 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Common Class B | - | - | 5 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Allowance For Doubtful Accounts Receivable | - | - | 6 | - | - | - | 9 | - | - | - | 15 | - | ||||||
| Treasury Stock Common Shares | - | - | 3 | - | - | - | 2 | - | - | - | 2 | - | ||||||
| Allowance For Doubtful Accounts Receivable Current | 5 | 5 | - | 6 | 7 | 8 | - | 12 | 14 | 15 | - | 15 | ||||||
| Preferred Units Outstanding | - | - | - | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Authorized | 8 | 8 | 8 | - | - | - | 8 | 8 | 8 | - | 8 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | - | - | - | - | - | 0 | 0 | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBIO-RAD LABORATORIES, INC. (BIO) — SEC Financial Statements & Analysis
BIO-RAD LABORATORIES, INC. (BIO) is a laboratory analytical instruments company, incorporated in DE. BIO-RAD LABORATORIES, INC. trades on NYSE as: BIO, BIO-B. BIO-RAD LABORATORIES, INC. (BIO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04. Based on that filing, BIO-RAD LABORATORIES, INC. carries a market cap of $7.85B, a P/E ratio of 35.31x, a P/B ratio of 1.09x, a P/S ratio of 4.14x, an enterprise value of $8.14B, and an EV/EBITDA multiple of 153.24x. On profitability, it posts a gross margin of 70.87%, an operating margin of 2.80%, a net margin of 11.73%, a Return on Equity (ROE) of 3.11%, a Return on Assets (ROA) of 2.17%, and a Return on Invested Capital (ROIC) of 0.44%. Per share, it reports EPS of $8.32, diluted EPS of $8.29, free cash flow per share of $13.20, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 0.50% year-over-year, net income growth of -30.33% year-over-year, and EPS growth of -29.08% year-over-year. On the balance sheet, it maintains a current ratio of 3.14x, a quick ratio of 2.18x, working capital of $2.06B, a debt-to-equity ratio of 0.43x, a debt ratio of 0.3, an interest coverage ratio of 1.09x, free cash flow of $353.10M (TTM), and net debt of $284.20M. Figures sourced from SEC EDGAR.
- Market Cap
- $7.85B
- P/E TTM
- 35.31x
- EPS TTM
- $8.32
- P/B TTM
- 1.09x
- ROE TTM
- 3.11%
- ROA TTM
- 2.17%
- Debt To Equity
- 0.43x
- Free Cash Flow TTM
- $353.10M
- Net Revenue TTM Growth 1Y
- 0.50%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIO-RAD LABORATORIES, INC. in?
BIO-RAD LABORATORIES, INC. (BIO) operates in the Laboratory Analytical Instruments industry.
What exchange does BIO trade on?
BIO-RAD LABORATORIES, INC. (BIO) trades on the NYSE.
Where is BIO-RAD LABORATORIES, INC. incorporated?
BIO-RAD LABORATORIES, INC. is incorporated in DE.
When was BIO-RAD LABORATORIES, INC. (BIO)'s most recent SEC filing?
BIO-RAD LABORATORIES, INC. (BIO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04.
What is BIO's market cap?
BIO-RAD LABORATORIES, INC. (BIO) has a market capitalization of $7.85B as of 2026-06-30.
What is BIO's P/E ratio?
BIO-RAD LABORATORIES, INC. (BIO)'s trailing twelve month P/E ratio is 35.31x as of 2026-06-30.
What is BIO's EPS (earnings per share)?
BIO-RAD LABORATORIES, INC. (BIO)'s trailing twelve month EPS is $8.32 as of 2026-06-30.
What is BIO's ROE (return on equity)?
BIO-RAD LABORATORIES, INC. (BIO)'s trailing twelve month Return on Equity (ROE) is 3.11% as of 2026-06-30.
What is BIO's ROA (return on assets)?
BIO-RAD LABORATORIES, INC. (BIO)'s trailing twelve month Return on Assets (ROA) is 2.17% as of 2026-06-30.
What is BIO's ROIC (return on invested capital)?
BIO-RAD LABORATORIES, INC. (BIO)'s trailing twelve month Return on Invested Capital (ROIC) is 0.44% as of 2026-06-30.
What is BIO's EV/EBITDA?
BIO-RAD LABORATORIES, INC. (BIO)'s trailing twelve month EV/EBITDA is 153.24x as of 2026-06-30.